Neurological Surgery

Publications

Found 32 results
Author Title Type [ Year(Desc)]
Filters: Author is Kaplitt, Michael G  [Clear All Filters]
2007
Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al..  2007.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369(9579):2097-105.
2010
Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M et al..  2010.  Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med. 2(54):54ra76.
2013
Gelfand Y, Kaplitt MG.  2013.  Gene therapy for psychiatric disorders.. World Neurosurg. 80(3-4):S32.e11-8.
2016
Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, M Cenci A, Svenningsson P, Greengard P, Kaplitt MG.  2016.  Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.. Proc Natl Acad Sci U S A. 113(5):1423-8.
Virk MS, Sagi Y, Medrihan L, Leung J, Kaplitt MG, Greengard P.  2016.  Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum.. Proc Natl Acad Sci U S A. 113(3):734-9.
Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P.  2016.  p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.. Proc Natl Acad Sci U S A. 113(5):1429-34.
2017
Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al..  2017.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al..  2017.  Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.
2018
Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Arbona RJRicart, Monette S et al..  2018.  AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease.. Hum Gene Ther Clin Dev. 29(1):24-47.
Kelm-Nelson CA, Brauer AFL, Barth KJ, Lake JM, Sinnen MLK, Stehula FJ, Muslu C, Marongiu R, Kaplitt MG, Ciucci MR.  2018.  Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.. Brain Res. 1680:1-12.
J Chazen L, Sarva H, Stieg PE, Min RJ, Ballon DJ, Pryor KO, Riegelhaupt PM, Kaplitt MG.  2018.  Clinical improvement associated with targeted interruption of the cerebellothalamic tract following MR-guided focused ultrasound for essential tremor.. J Neurosurg. 129(2):315-323.
Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ et al..  2018.  Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.. Sci Transl Med. 10(469)
Fishman PS, W Elias J, Ghanouni P, Gwinn R, Lipsman N, Schwartz M, Chang JW, Taira T, Krishna V, Rezai A et al..  2018.  Neurological adverse event profile of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor.. Mov Disord. 33(5):843-847.
Stavarache MA, Petersen N, Jurgens EM, Milstein ER, Rosenfeld ZB, Ballon DJ, Kaplitt MG.  2018.  Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound. J Neurosurg. 130(3):989-998.
2019
J Chazen L, Stradford T, Kaplitt MG.  2019.  Correction to: Cranial MR-guided Focused Ultrasound for Essential Tremor : Technical Considerations and Image Guidance.. Clin Neuroradiol. 29(2):359.
J Chazen L, Stradford T, Kaplitt MG.  2019.  Cranial MR-guided Focused Ultrasound for Essential Tremor : Technical Considerations and Image Guidance.. Clin Neuroradiol. 29(2):351-357.
Kaplitt MG.  2019.  Gene-targeting approaches for movement disorders: recent advances.. Curr Opin Neurol. 32(4):566-570.
D'Souza M, Chen KS, Rosenberg J, W Elias J, Eisenberg HM, Gwinn R, Taira T, Chang JWoo, Lipsman N, Krishna V et al..  2019.  Impact of skull density ratio on efficacy and safety of magnetic resonance-guided focused ultrasound treatment of essential tremor.. J Neurosurg. 132(5):1392-1397.
Parker WE, Weidman EK, J Chazen L, Niogi SN, Uribe-Cardenas R, Kaplitt MG, Hoffman CE.  2019.  Magnetic resonance-guided focused ultrasound for ablation of mesial temporal epilepsy circuits: modeling and theoretical feasibility of a novel noninvasive approach.. J Neurosurg. :1-8.
Weidman EK, Kaplitt MG, Strybing K, J Chazen L.  2019.  Repeat magnetic resonance imaging-guided focused ultrasound thalamotomy for recurrent essential tremor: case report and review of MRI findings.. J Neurosurg. :1-6.
Weidman EK, Kaplitt MG, Strybing K, J Chazen L.  2019.  Repeat magnetic resonance imaging-guided focused ultrasound thalamotomy for recurrent essential tremor: case report and review of MRI findings.. J Neurosurg. :1-6.
2020
Amin-Hanjani S, Bambakidis NC, Barker FG, Carter BS, Cockroft KM, Du R, Fraser JF, Hamilton MG, Huang J, Jane JA et al..  2020.  Editorial. COVID-19 and neurosurgical practice: an interim report.. J Neurosurg. :1-2.
Ebani EJ, Kaplitt MG, Wang Y, Nguyen TD, Askin G, J Chazen L.  2020.  Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease.. Clin Imaging. 68:94-98.
2021
J Chazen L, Stavarache M, Kaplitt MG.  2021.  Cranial MR-Guided Focused Ultrasound: Clinical Challenges and Future Directions.. World Neurosurg. 145:574-580.
González-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L et al..  2021.  Disruption of mitochondrial complex I induces progressive parkinsonism.. Nature.